| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/30/2008 | EP1916302A1 Method of producing lymphocytes |
| 04/30/2008 | EP1916256A2 Search for cancer markers by a novel screening method |
| 04/30/2008 | EP1916000A1 Use of measles virus nucleoprotein for treating atherosclerosis |
| 04/30/2008 | EP1915999A1 N-terminally monopegylated human growth hormone conjugates, process for their preparation, and methods of use thereof. |
| 04/30/2008 | EP1915452A2 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress |
| 04/30/2008 | EP1915451A2 Method for producing arachidonic acid and/or eicosapentaenoic acid in useful transgenic plants |
| 04/30/2008 | EP1915396A2 Use of panton-valentine leukocidin for treating and preventing staphylococcus infections |
| 04/30/2008 | EP1915393A1 Selective vpac2 receptor peptide agonists |
| 04/30/2008 | EP1915392A2 Vegf-d and functional fragments thereof for bone repair |
| 04/30/2008 | EP1915391A1 Sra binding protein |
| 04/30/2008 | EP1915389A2 Differentially protected orthogonal lanthionine technology |
| 04/30/2008 | EP1915388A1 F11 receptor (f11r) antagonists as therapeutic agents |
| 04/30/2008 | EP1915060A2 Process for controlling protein to salt ratio in animal muscle protein composition and protein composition reference to related application |
| 04/30/2008 | EP1631584B1 Method for the detection of the activity of gamma-secretase |
| 04/30/2008 | EP1581555B1 Chimeric alpha q-gustducin g-proteins |
| 04/30/2008 | EP1572084A4 Mammalian genes involved in viral infection and tumor suppression |
| 04/30/2008 | EP1458240B1 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 04/30/2008 | EP1419177B1 A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine |
| 04/30/2008 | EP1406927B1 Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis |
| 04/30/2008 | EP1406651B1 Cosmetic or dermatological use of a peptide for promoting adhesion between skin cells |
| 04/30/2008 | EP1399023B1 COMPOSITIONS FOR SYSTEMIC ADMINISTRATION OF SEQUENCES ENCODING BONE MORPHOGENETIC PROTEINS& x9; |
| 04/30/2008 | EP1307486B1 Somatostatin analogues |
| 04/30/2008 | EP1213297B1 Tachykinin peptides, precursor peptides thereof and genes encoding the same |
| 04/30/2008 | EP1212417B1 Promotion or inhibition of angiogenesis and cardiovascularization |
| 04/30/2008 | EP1208116B1 Somatostatin analogs, radiolabelled derivatives thereof and their use |
| 04/30/2008 | EP1183360B1 Modified cytokine for its stabilisation |
| 04/30/2008 | EP1165613B1 Melanocortin receptor ligands |
| 04/30/2008 | EP1127072B1 Method for detecting and purifying tcd8+ lymphocyte populations, specific of peptides present in the context of hla |
| 04/30/2008 | EP1058728B1 V-like domain binding molecules |
| 04/30/2008 | EP0983351B1 Nucleic acid binding proteins |
| 04/30/2008 | EP0983350B1 Nucleic acid binding proteins |
| 04/30/2008 | EP0730657B1 Composition for the in vivo production of therapeutic products |
| 04/30/2008 | CN101171337A Methods and composition related to in vivo imaging of gene expression |
| 04/30/2008 | CN101171334A Methods of producing proteins having triple-helix structure |
| 04/30/2008 | CN101171262A Glucagon-like-peptide-2 (GLP-2) analogues |
| 04/30/2008 | CN101171077A Affinity adsobents for fibrinogen |
| 04/30/2008 | CN101171076A Affinity adsorbents for factor viii and von willebrand's factor |
| 04/30/2008 | CN101171035A Methods and compositions for modulating TWEAK and FN14 activity |
| 04/30/2008 | CN101168565A Nitric oxide-blocked cross-linked tetrameric hemoglobin |
| 04/30/2008 | CN101168564A Human antibiotic peptide and use for derivative thereof |
| 04/30/2008 | CN101168563A Anticancer active peptide |
| 04/30/2008 | CN101168562A CBP C end protein, monoclonal antibody thereof, preparation and use of the same |
| 04/30/2008 | CN100385006C Method for secretory production of glycoprotein having human-type sugar chain using plant cell |
| 04/30/2008 | CN100385005C Methods for the production of multimeric proteins, and related compositions |
| 04/30/2008 | CN100385004C Cold shock inducible expression and production of heterologous polypeptides |
| 04/30/2008 | CN100385002C Di- or oligomer of a dimer, trimer, quatrometer or pentamer of recombinant fusion proteins |
| 04/30/2008 | CN100385000C Application of true halophyte cytoplasma membrane water channel protein genes |
| 04/30/2008 | CN100384999C Salt tolerant, drought resistance, and cold proof gene of transcriptional factor in DREB class of poplar adjusted and controlled by code, and application |
| 04/30/2008 | CN100384998C Method for preparing recombinant goose interleukin-2 protein and its application |
| 04/30/2008 | CN100384997C Lefteye flounder disease resistance related MHC gene marker and subsidiary breeding method |
| 04/30/2008 | CN100384996C Marker proteins for diagnosing liver disease and method of diagnosing liver disease using the same |
| 04/30/2008 | CN100384995C Transformed silkworm producing human collagen |
| 04/30/2008 | CN100384988C Chicken astrovirus type 2 |
| 04/30/2008 | CN100384880C Modified peptides as therapeutic agents |
| 04/30/2008 | CN100384879C Modified peptides as therapeutic agents |
| 04/30/2008 | CN100384877C Antibody ('11c7') anti nogo a and its pharmaceutical use |
| 04/30/2008 | CN100384875C 蛋白质 Protein |
| 04/30/2008 | CN100384873C Chimeric antagonist ANTH1 |
| 04/30/2008 | CN100384872C Method for purifying mouse herve growth factor for scale-production |
| 04/30/2008 | CN100384871C Isolated fluorescent protein from clytia gregaria CGFP and use thereof |
| 04/30/2008 | CN100384870C Fat metabolic regulation-related transcription factor GmDofA and its coding gene and use |
| 04/30/2008 | CN100384482C Method of examining effect of angiogenesis inhibitors mediated by the inhibition of integrin expression |
| 04/30/2008 | CA2564924A1 Design of interferon-inducible protein-10 (ip-10 or cxcl10) chemokine analogs for the treatment of human diseases |
| 04/29/2008 | US7365242 Suppression of specific classes of soybean seed protein genes |
| 04/29/2008 | US7365184 B. anthracis prevention and treatment: mutant B. anthracis lacking luxS activity and furanone inhibition of growth, AI-2 quorum sensing, and toxin production |
| 04/29/2008 | US7365182 Comprises nucleotide sequences coding vernalization independence polypeptides (VIP) for contolling the time of flowering in agriculure important crop plants such as tomatoes, corn and lettuce |
| 04/29/2008 | US7365181 Probes for chondrogenesis |
| 04/29/2008 | US7365177 Expression vector comprising nucleotide sequences which code chromogenic protein for use in transformation and generation of fish animal models of disease |
| 04/29/2008 | US7365175 Wit 3.0, a novel gene to control soft tissue wound healing |
| 04/29/2008 | US7365172 Cytoprotective agent to protect a patient undergoing cancer cytotoxic therapy from gastrointestinal side effects; peptide that is derived from a loop or "lollipop" region of transforming growth factor; stimulate hematopoiesis; diabetes, rheumatoid arthritis, lupus, and multiple sclerosis |
| 04/29/2008 | US7365171 Chemotactic cytokine for use in diagnosis, prevention and treatment of tumors |
| 04/29/2008 | US7365170 Reagents for regulation of metabolic events, such as those mediated by adiponectin and adiponectin agonists. The invention also provides screening assays for identification of biologically active agents, diagnostic and therapeutic agents |
| 04/29/2008 | US7365169 T-bet antibodies |
| 04/29/2008 | US7365165 Suitable for lyophilization, protein capable of binding and inhibiting the biological action of IL-1,histidine, glycine, arginine, sucrose, stability; resistant to degradation, aggregation, oxidation, and other degenerative processes while in the freeze dried state |
| 04/29/2008 | US7365164 Screening method for genes of brewing yeast |
| 04/29/2008 | US7365163 Isolation nulceic acid; genetic engineering; screening antagonist; aminobutyric acid receptor; diagnostics for detecting aberrant GABAA receptor epsilon subunit (GABRE) and ET2 expression, therapy of disorders involving ET2 and GABRE |
| 04/29/2008 | US7365162 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 04/29/2008 | US7365161 Mutant tyrosine repressor which does not require tyrosine to induce expression of the tyrosine phenol-lyase gene |
| 04/29/2008 | US7365160 Membrane protein for use as diagnostic tool in detection and screening of xenobiotics; drug screening |
| 04/29/2008 | US7365159 Plasminogen fragments containing kringle region domains having anti-angiogenic activity and terned angiostatin protein. The plasminogen fragments of the present invention may be used for the treatment of angiogenesis-dependent diseases such as |
| 04/29/2008 | US7365158 Antiproliferative agents; anticancer agents |
| 04/29/2008 | US7365157 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of immunological disorders |
| 04/29/2008 | US7365156 PRO1316 polypeptides |
| 04/29/2008 | US7365155 Immunoregulator |
| 04/29/2008 | US7365154 Use as an immunogen to generate anti-integrin antibodies; a mimotope; vaccinating against angiogenic and metastatic diseases |
| 04/29/2008 | US7365153 Biologically active peptide and agent containing the same |
| 04/29/2008 | US7365052 Tendon-inducing methods |
| 04/29/2008 | US7365051 Compounds with improved cartilage-inducing and/or bone-inducing activity |
| 04/29/2008 | US7364903 Cell lines that stably or transiently express a functional umami (T1R1/T1R3) taste receptor |
| 04/29/2008 | US7364894 Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
| 04/29/2008 | US7364893 infectious laryngotracheitis viral genome which contains a deletion in the glycoprotein gG gene, US2 gene, UL47-like gene. ORF4 gene; polypeptide is derived from infectious bronchitis virus, Newcastle disease virus, infectious bursal disease virus, and Marek's disease virus; vaccines |
| 04/29/2008 | US7364889 Catalytically active peptides |
| 04/29/2008 | US7364876 ADIP protein and use thereof |
| 04/29/2008 | US7364871 screening for candidates that modulate interaction of MEKK and MIF1 comprising a) contacting MIF1 protein with MEKK protein and a candidate molecule, and b) detecting modulation of the interaction of MIF1 and MEKK; antagonists or agonists of MIF1/MSP58-MEKK1 binding |
| 04/29/2008 | US7364870 screening assay to identify compounds that inhibit or promote formation of a protein complex; two-hybrid assay system: a) a first fusion protein is MK2 polypeptide and b) a second fusion protein is a Shc polypeptide; measuring interaction between fusion proteins in presence of compound; antiinflammatory |
| 04/29/2008 | US7364868 Using nuclear and lower cytosolic localization of kruppel-like transcription factors to diagnose and prognose viability of individuals with cell proliferative disorders |
| 04/29/2008 | US7364867 Nucleotide sequences which code a membrane protein for use in flavor intensification of in food, beverages or pharmaceuticals |
| 04/29/2008 | US7364866 Insecticides; generating immunology response |
| 04/29/2008 | US7364865 Antibodies to myeloid progenitor inhibitory factor-1 (MPIF-1) |
| 04/29/2008 | US7364864 ANGE gene in atopy |